A-Z of Health Research Equity: C is for Co-Creation
Read the blog to learn more about what is co-creation and how to implement this into your practices with patients and health research
Navigating the maze of health disparities and clinical trial participation in Europe
Dive deep into the health disparities facing different populations in Europe, including ethnic minorities, migrants, refugees, LGBTQIA+ communities, individuals with disabilities, and those from various socioeconomic and educational backgrounds.
A–Z of Health Research Equity: D is for Diversity
The next instalment of our A–Z of Health Research Equity blog series is now live! Dr Heidi Green delves into the thing that underpins everything we do at COUCH Health: Diversity.
A–Z of Health Research Equity: E is for Engagement
We started this blog series with A is for Accessibility, where I talked about the three pillars of accessibility and why inclusive and accessible health research is so important. Today, we’re revisiting accessibility, this time in the context of another huge part of our work at COUCH Health. In this post, I’m talking about Engagement.
How cultural safety boosts clinical trial patient recruitment
Discover how embracing cultural safety can dramatically increase clinical trial patient recruitment, ensuring more inclusive and effective health outcomes. Learn key strategies for bridging cultural gaps in clinical trials
A–Z of Health Research Equity: F is for Feedback
Providing feedback to patients helps to support research transparency and contributes to building trust with people unsure about taking part in research. Read this blog to discover the importance of patient feedback in clinical research.
The UK’s push for evidence of patient engagement in ethics submissions for clinical trials
Discover how the UK is leading the way in clinical research by requiring evidence of patient co-creation in ethics submissions, transforming drug development and patient care.
A–Z of Health Research Equity: G is for Goals
Diversity goals are often ambiguous. The concept of ensuring the population of a trial is diverse is a vague task, so the goal becomes vague, too. To show you what I mean by that, read this blog.
The impact of socioeconomic factors on clinical trial participation: A global and local perspective
Discover how socioeconomic factors influence clinical trial participation across different regions, including the United States, Mexico, the United Kingdom, and Italy. Learn about barriers and strategies to enhance inclusivity and ensure diverse, representative study populations
A–Z OF HEALTH RESEARCH EQUITY: H IS FOR HISTORY
Understanding the history of clinical research offers a unique perspective on how past practices have shaped modern medicine. Read this blog to learn more.
